Short report: Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006)

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 2, 2012, Pages 257-260

  Ferreira E Vasconcellos, Érica De Camargo ^a,b,c,d,e   Fernandes Pimentel, Maria Inês ^a,b,c,d,e   De Oliveira Schubach, Armando ^a,b,c,d,e   Carvalhaes De Oliveira, Raquel De Vasconcellos ^a,b,c,d,e   Azeredo Coutinho, Rilza Beatriz ^a,b,c,d,e,f   Da Conceição Silva, Fátima ^a,b,c,d,e   De Matos Salgueiro, Mariza ^a,b,c,d,e   Soares Moreira, João ^a,b,c,d,e   De Fátima Madeira, Maria ^a,b,c,d,e   Baptista, Cibele ^a,b,c,d,e   Valete Rosalino, Cláudia Maria ^a,b,c,d,e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c MINISTÉRIO DA SAÚDE   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e Scientific and Technology Development National Council   (Brazil)

^f Hospital Federal de Bonsucesso Dermatologia Rio de Janeiro   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MEGLUMINE ANTIMONATE; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOSA; SKIN LEISHMANIASIS; SYSTEMIC THERAPY; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WOUND HEALING; ADOLESCENT; AGED; BRAZIL; GROWTH, DEVELOPMENT AND AGING; INTRALESIONAL DRUG ADMINISTRATION; LEISHMANIA; MIDDLE AGED; NONPARAMETRIC TEST; PRESCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPROTOZOAL AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; STATISTICS, NONPARAMETRIC; URBAN POPULATION; YOUNG ADULT;

EID: 84864875698     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0612     Document Type: Article

References (26)

1. Ministério da Saúde, 2010. Manual de Vigilância da Leishmaniose Tegumentar Americana. Saúde SdVe, ed: Editora MS, 78.
2. Goodwin LG, 1995. Pentostan (sodium stibogluconate); a 50-year personal reminiscence. Trans R Soc Trop Med Hyg 89: 339-341.
3. Herwaldt BL, 1999. Leishmaniasis. Lancet 354: 1191-1199. (Pubitemid 29460458)
4. Andersen EMC-SM, Llanos-Cuentos A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD, 2005. Comparison of meglumine antimoniate and pentamidine for perureian cutaneous leishmaniasis. J Trop Med Hyg 72: 133-137. (Pubitemid 41278895)
5. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RA Jr, Magill AJ, Endy TP, Coyne PE, Grogl M, Benson PM, Beard JS, Tally JD, Gambel JM, Kreutzer RD, Oster CN, 1998. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27: 1457-1464. (Pubitemid 29242421)
6. Ribeiro AL, Drummond JB, Volpini AC, Andrade AC, Passos VM, 1999. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonialmeglumine. Braz JMed Biol Res 32: 297-301. (Pubitemid 29169303)
7. DAIDS, 2004. Division of AIDS table for grading the severity of adult and pediatric adverse events: DAIDS Regulatory Support Center.
8. Romero GA, Mendonça S, Schubach A, Noronha E, Matos M, Dietze R, 2006. O desafio para a realização de ensaios clínicos em leishmaniose tegumentar. Revista da Sociedade Brasileira de Medicina Tropical 39 (III Suppl): 100-103.
9. Schubach AO, Marzochi KBF, Moreira JS, Schubach TMP, Araújo ML, Francesconi-do-Vale AC, Passos SRL, Marzochi MC, 2005. Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate. Rev Soc Bras Med Trop 38: 213-217. (Pubitemid 40675628)
10. Marsden P, Llanos Cuentas E, Lago E, Cuba C, Barreto A, Costa J, Jones T, 1984. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia - Brazil. An area of Leishmania braziliensis braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 17: 179-186.
11. Ampuero J, 2009. Efficacy and safety of low-dose pentavalent antimonial for treatment of cutaneous leishmaniasis by Leishmania (Viannia) braziliensis in Bahia, Brazil: a randomized clinical trial. Thesis, Núcleo de Medicina Tropical. Brasília - DF: Universidade de Brasília, 260.
12. Schubach A, Marzochi MC, Cuzzi-Maya T, Oliveira AV, Araújo ML, Oliveira AL, Pacheco RS, Momen H, Conceição-Silva F, Coutinho SG, Marzochi KB, 1998. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 58: 824-827. (Pubitemid 28307408)
13. de Paula CDSJ, Cardoso DR, Sampaio RN, 2003. A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis. Rev Soc Bras Med Trop 36: 365-371. (Pubitemid 36873778)
14. Saldanha AC, Romero GA, Guerra C, Merchan-Hamann E, Macedo VO, 2000. Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity. Rev Soc Bras Med Trop 33: 383-388. (Pubitemid 30604786)
15. Soto J, Buffet P, Grogl M, Berman J, 1994. Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg 50: 107-111. (Pubitemid 24059993)
16. de Camargo Ferreira EV, de Oliveira Schubach A, Valete-Rosalino CM, de Souza Coutinho R, Conceicao-Silva F, de Matos Salgueiro M, Rosandiski Lyra M, Soares Moreira J, Azeredo-Coutinho RB, Fernandes Pimentel MI, Roberto Mortari S, de Fatima Madeira M, Pereira Quintella L, Baptista C, de Almeida Marzochi MC, 2010. American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil. J Am Geriatr Soc 58: 614-616.
17. Claros P, Wienberg P, Gonzalez MA, Claros A, Claveria MA, Lopez P, 1996. Intralesional treatment of cutaneous leishmaniasis: a report of two cases. Acta Otorrinolaringol Esp 47: 67-70. (Pubitemid 26228779)
18. Harms G, Chehade AK, Douba M, Roepke M, Mouakeh A, Rosenkaimer F, Bienzle U, 1991. A randomized trial comparing a pentavalent antimonial drug and recombinant interferongamma in the local treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 85: 214-216.
19. Sharquie KEA-TK, Chu AC, 1988. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 119: 53-57.
20. Tallab TM, Bahamdam KA, Mirdad S, Johargi H, Mourad MM, Ibrahim K, el Sherbini AH, Karkashan E, Khare AK, Jamal A, 1996. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol 35: 594-597. (Pubitemid 26261937)
21. Schubach A, Haddad F, Oliveira-Neto MP, Degrave W, Pirmez C, Grimaldi G Jr, Fernandes O, 1998. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911-914. (Pubitemid 28397251)
22. Mendonça MG, De Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG, 2004. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 189: 1018-1023. (Pubitemid 38373094)
23. Schubach A, Cuzzi-Maya T, Oliveira AV, Sartori A, de Oliveira-Neto MP, Mattos MS, Araujo ML, Souza WJ, Haddad F, Perez Mde A, Pacheco RS, Momen H, Coutinho SG, de Almeida Marzochi MC, Marzochi KB, da Costa SC, 2001. Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem Inst Oswaldo Cruz 96: 987-996. (Pubitemid 33643305)
24. Wortmann GW, Miller RS, Blazes D, Oster CN, 2000. Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 31: 199-201. (Pubitemid 32268968)
25. Marsden PD, Tada MS, Barreto AC, Cuba CC, 1984. Spontaneous healing of Leishmania braziliensis braziliensis skin ulcers. Trans R Soc Trop Med Hyg 78: 561-562. (Pubitemid 14030595)
26. Zajtchuk JT, Netto EM, Grogl M, Neafie RC, Hessel CR, de Magalhaes AV, Marsden PD, 1989. Mucosal leishmaniasis in Brazil. Laryngoscope 99: 925-939. (Pubitemid 19230631)